NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 10, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2025

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

N-acetyl-L-cysteine

N-acetyl-L-cysteine (Yiweishi) capsules (Guangdong Renrenkang Pharmaceutical Industry) will be given orally 400mg three times a day from day 1 to day 28 after chemotherapy. In case of drug allergy such as nausea, vomiting, rash and bronchospasm, and disease relapse, to discontinue the drug immediately.

Trial Locations (1)

100032

Yuan Kong, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT06024031 - NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy | Biotech Hunter | Biotech Hunter